Description
A capsid-binding antiviral agent; inhibits the cytopathic effects of HRV2 and HRV14 in HeLa Ohio cells (EC50s = 1 and 5 ng/ml, respectively), as well as in a panel of 39 HRV clinical isolates (median EC50 = 7.3 ng/ml); inhibits replication in a panel of 21 EV71 isolates (average EC50 = 0.7 µM)
Formal name: 3-ethoxy-6-[2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy]-1,2-benzisoxazole
Synonyms: BTA798
Molecular weight: 382.5
CAS: 439085-51-5
Purity: ≥95%
Formulation: A crystalline solid